Over the past years the CIHR has provided substantial funding to Dr. Menzies and his research team at the TB Centre. Putting the funds to good use, Dr. Menzies has defined a treatment protocol for TB, which is now in use across North America. Now it is time to take that research further.
In response to a joint application made by CAB-V (Canada, Australia, Benin and Vietnam), an international network led by Dr. Menzies, the CIHR-III has awarded the McGill International TB Centre a further $17.2 million over the next ten years to continue its research and clinical trials on the treatment, diagnosis and prevention of TB. Further studies are being planned for the near future at sites and with co-investigators across Canada and around the world.
About Dr. Menzies:
Read more about Dr. Menzies and TB Research here:
- Clinical and epidemiologic research in Tuberculosis, Canadian Institutes of Health Research, Institute of Infection and Immunity, March 24, 2021.
- McGill International TB Centre receives $17.2 M for clinical trials and clinical research on tuberculosis, Research Institute of the MUHC, March 25, 2021.